Axxia Pharmaceuticals
Innovative polymeric implants for precise, long-term pain relief therapy.
Innovative polymeric implants for precise, long-term pain relief therapy.
Axxia Pharmaceuticals, Inc. is a biotechnology and pharmaceutical company founded in 1998 and headquartered in Bel Air, Maryland. The company specializes in innovative polymeric implants for precise, long-term pain relief therapy. Their flagship product is a subcutaneous polymeric implant that offers controlled release of hydromorphone with zero-order kinetics, catering to patients with moderate to severe chronic pain, particularly those suffering from cancer. In March 2012, Axxia Pharmaceuticals received a $300.00K investment in a Seed Round. The company continues to make strides in the biotechnology and healthcare industries, positioning itself as a promising venture for potential investors keen on innovative drug delivery technologies.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $300.00K | - | 01 Mar 2012 |
No recent news or press coverage available for Axxia Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
